Диагностика и лечение отека легких

Автор: Терещенко Сергей Николаевич, Жиров Игорь Витальевич, Наконечников Сергей Николаевич

Журнал: Евразийский кардиологический журнал @eurasian-cardiology-journal

Статья в выпуске: 2, 2012 года.

Бесплатный доступ

Представлены современные сведения о патогенезе, диагностике и лечебных стратегиях у пациентов с кардиогенным отеком легких. В табличной форме изложен дифференциальный диагноз, приведены алгоритмы медикаментозной и респираторной поддержки.

Кардиогенный отек легких, инотропные средства, вазодилататоры, неинвазивная вентиляция легких

Короткий адрес: https://sciup.org/14342715

IDR: 14342715

Список литературы Диагностика и лечение отека легких

Swedberg К., Nieminen M.S., Cleland J., et all. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26: 1115-1140
Mariell Jessup, M.D., and Susan Brozena, M.D. Heart Failure NEJM 2003, N 20, Volume 348: 2007-2018.
Alla F., Zannad F., Filippatos G. Epidemiology of acute heart failure syndromes at Heart Fail Rev. 2007 Jun; 12(2): 91-5.
Konstam M.A. Progress in heart failure management? Lessons from the real world. Circulation 2000; 102: 1076-1078.
Cleland J.G., Swedberg K., Follath F. et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463.;
Fox K.F., Cowie M.R., Wood D.A. et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001; 22: 228-236.;
ATKhadra A.S., Salem D.N., Rand W.M. et al. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol 1998; 31: 749-753
Mosesso V. N., Dunford J., Blackwel T., Griswell J. K. Prehospital therapy for acute congestive heart failure: state of the art. Prehospital Emergency Care January 2003; 7: 13-23
Nieminen M.S., D. Brutsaert, K. Dickstein at all. EuroHeart Failure Survey II): a survey on hospitalized acute heart failure patients: description of population European Heart Journal Vol. 27, N 22 Pp. 2725-2736 2006
Cotter G., Kaluski E., Moshkovitz Y., Milovanov O., Krakover R., Vered Z. Pulmonary edema: new insight on pathogenesis and treatment. Curr Opin Cardiol. 2001; 16: 159-63.
Mitchell J.E., Palta S. New diagnostic modalities in the diagnosis of heart failure.//J Natl Med Assoc. -2004 Nov. -№ 6(11). -p. 1424-30.
Berger R., Huelsman M., Strecker K., et al. В-type natriuretic peptide predicts sudden death in patients with chronic heart failure.//Circulation. -2002. -№ 105. -p.2392-2397
Torbjorn Omlandt Heart failure in the emergency department*: Is В-type natriuretic peptide a better prognostic indicator than clinical assessment?.//Journal of the American College of Cardiology. -September 2004. -Volume 44. -Issue 6, 15. -p. 1334-1336
Muders F., Kromer E.P., Griese D.P., et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.//Am Heart J. -1997. -№ 134. -p. 442-449.
Maeda K., Takayoshi T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.//Am Heart J. -1998. -№ 135. -p. 825-832.
Aberle D.R., Wiener-Kronish J.P., Webb W.R., Matthay M.A. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988; 168: 73-9.
Duane P.G., Colice G.L. Impact of noninvasive studies to distinguish volume overload from ARDS in acutely ill patients with pulmonary edema: analysis of the medical literature from 1966 to 1998. Chest 2000; 118: 1709-17.
Lorraine B. Ware, M.D., and Michael A. Matthay, M.D. Acute Pulmonary Edema NEJM 2005 N 26Volume 353: 2788-2796
Swan H.J., Ganz W., Forrester J., Marcus H., Diamond G., Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283: 447-51.
Masip J., Betbese A.J., Paez J. et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 2000; 356: 2126-2132.
Sharon A., Shpirer I., Kaluski E. et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAPventilation combined with conventional treatment for severe pulmonary edema. J. Am Coll Cardiol 2000; 36: 832-837.
Brater D.C. Resistance to loop diuretics. Why it happens and what to do about it. Drugs 1985; 30: 427-443
Kramer W.G., Smith W.B., Ferguson J. et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J. Clin Pharmacol 1996; 36: 265-270.
Channer K.S., McLean K.A., Lawson-Matthew P. et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J. 1994; 71: 146-150.
Cotter G., Metzkor E., Kaluski E. et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393.
Cotter G., Weissgarten J., Metzkor E. et al. Increased toxicity of highdose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther 1997; 62: 187-193.
Katz A.M. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 1986; 73: lll 184-11190
Kivikko M., Lehtonen L., Colucci W.S. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003; 107: 81-86.
Innes C.A., Wagstaff A.J. Levosimendan: A review of its use in the management of acute decompensated heart failure. Drugs 2003,63: 2651-2671.
Follath F., Cleland J.G., Just H. et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202.
Slawsky M.T., Colucci W.S., Gottlieb S.S. et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 2222-2227.

Еще

Статья научная